Keck School of Medicine researchers receive $12 million grant to study early liver transplantation

Alcohol-associated liver disease accounts for 50% of liver-related deaths, and its rates are rising worldwide.

Gritstone’s Phase 2 cancer vaccine trial misses the mark, stock spirals down

Gritstone bio’s stock took a tumble in premarket trading Tuesday morning following mixed data from a Phase 2 study of its cancer vaccine, but it’s

April 3, 2024

Let’s leverage graduate medical education to increase Medicaid re-enrollment

Lately, we’ve seen two distinct lines at our hospitals. We would all be healthier if we brought the two lines together. The first line forms

November 2, 2023

Eli Lilly gets FDA approval to sell Mounjaro as obesity drug called Zepbound

Eli Lilly’s blockbuster drug tirzepatide, sold as Mounjaro for type 2 diabetes, has been cleared to treat obesity, making it the second in a highly

November 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.